Pharma Native ApS: Financial statements 2025
CVR: 44114976
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Pharma Native ApS (CVR 44114976) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 989,531 and a net result of DKK 124,011 compared with DKK 77,485 the year before. That is a decrease of 35.6% compared with the year before. Equity in the 2025 report amounted to DKK 255,959. The solvency ratio was 66.3%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 989,531
- Profit/Loss
- DKK 124,011
- Equity
- DKK 255,959
- Total Assets
- DKK 386,227
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 990 t. | 124 t. | 256 t. | 1 |
| 2024 | - | 1.5 mio. | 77 t. | 267 t. | 1 |
How creditworthy is Pharma Native ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Pharma Native ApS has published its annual report for 2024. Gross profit came to DKK 1,537,564, and the net result was DKK 77,485.
About Pharma Native ApS
Pharma Native ApS is a Danish company of the type Anpartsselskab based in Værløse, founded in 2023. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Jacob Ekstrøm. The company is owned by Jacob Ekstrøm. In 2025, the company reported a gross profit of DKK 989,531 and a net result of DKK 124,011 compared with DKK 77,485 the year before. Equity in the 2025 report amounted to DKK 255,959.